222 related articles for article (PubMed ID: 19017988)
1. OX40 drives protective vaccinia virus-specific CD8 T cells.
Salek-Ardakani S; Moutaftsi M; Crotty S; Sette A; Croft M
J Immunol; 2008 Dec; 181(11):7969-76. PubMed ID: 19017988
[TBL] [Abstract][Full Text] [Related]
2. The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.
Salek-Ardakani S; Flynn R; Arens R; Yagita H; Smith GL; Borst J; Schoenberger SP; Croft M
J Clin Invest; 2011 Jan; 121(1):296-307. PubMed ID: 21183789
[TBL] [Abstract][Full Text] [Related]
3. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.
Zhao Y; Croft M
Immunol Lett; 2012 Jan; 141(2):220-6. PubMed ID: 22037570
[TBL] [Abstract][Full Text] [Related]
4. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
[TBL] [Abstract][Full Text] [Related]
5. Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection.
Salek-Ardakani S; Moutaftsi M; Sette A; Croft M
J Virol; 2011 Sep; 85(17):9051-9. PubMed ID: 21715499
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
7. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus.
Zhao Y; De Trez C; Flynn R; Ware CF; Croft M; Salek-Ardakani S
J Immunol; 2009 May; 182(10):6278-86. PubMed ID: 19414781
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
[TBL] [Abstract][Full Text] [Related]
9. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
[TBL] [Abstract][Full Text] [Related]
10. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.
Green S; Ennis FA; Mathew A
Vaccine; 2011 Feb; 29(8):1666-76. PubMed ID: 21195803
[TBL] [Abstract][Full Text] [Related]
11. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
12. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.
Seneschal J; Jiang X; Kupper TS
J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845
[TBL] [Abstract][Full Text] [Related]
13. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.
Salek-Ardakani S; Arens R; Flynn R; Sette A; Schoenberger SP; Croft M
J Immunol; 2009 Mar; 182(5):2909-18. PubMed ID: 19234186
[TBL] [Abstract][Full Text] [Related]
14. Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus.
Mota BE; Gallardo-Romero N; Trindade G; Keckler MS; Karem K; Carroll D; Campos MA; Vieira LQ; da Fonseca FG; Ferreira PC; Bonjardim CA; Damon IK; Kroon EG
PLoS One; 2011 Apr; 6(4):e18924. PubMed ID: 21526210
[TBL] [Abstract][Full Text] [Related]
15. Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo.
Redmond WL; Gough MJ; Weinberg AD
Eur J Immunol; 2009 Aug; 39(8):2184-94. PubMed ID: 19672905
[TBL] [Abstract][Full Text] [Related]
16. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism.
Humphreys IR; Loewendorf A; de Trez C; Schneider K; Benedict CA; Munks MW; Ware CF; Croft M
J Immunol; 2007 Aug; 179(4):2195-202. PubMed ID: 17675479
[TBL] [Abstract][Full Text] [Related]
17. Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.
Hu Z; Wang J; Wan Y; Zhu L; Ren X; Qiu S; Ren Y; Yuan S; Ding X; Chen J; Qiu C; Sun J; Zhang X; Xiang J; Qiu C; Xu J
J Virol; 2014 May; 88(10):5356-68. PubMed ID: 24554667
[TBL] [Abstract][Full Text] [Related]
18. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
[TBL] [Abstract][Full Text] [Related]
19. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
[TBL] [Abstract][Full Text] [Related]
20. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD
J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
